Ju Guo

670 total citations
41 papers, 458 citations indexed

About

Ju Guo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ju Guo has authored 41 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Ju Guo's work include Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (6 papers) and Renal cell carcinoma treatment (5 papers). Ju Guo is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (6 papers) and Renal cell carcinoma treatment (5 papers). Ju Guo collaborates with scholars based in China, United States and Mexico. Ju Guo's co-authors include Bin Fu, Gongxian Wang, Jieping Hu, Xiaocheng Zhou, Yuanyuan Li, Wei Huang, Cheng Zhang, Jun Deng, Luyao Chen and Xiaoqiang Liu and has published in prestigious journals such as Oncogene, ACS Applied Materials & Interfaces and Molecular Cancer.

In The Last Decade

Ju Guo

36 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Guo China 13 286 190 161 74 67 41 458
Junjie Cen China 15 470 1.6× 341 1.8× 136 0.8× 94 1.3× 54 0.8× 31 647
Di Gu China 11 201 0.7× 117 0.6× 189 1.2× 83 1.1× 29 0.4× 37 399
Jintao Zhuang China 9 250 0.9× 162 0.9× 71 0.4× 46 0.6× 62 0.9× 27 376
Lucie Hamel Canada 12 181 0.6× 109 0.6× 161 1.0× 70 0.9× 24 0.4× 21 373
Joseph Brito United States 8 207 0.7× 74 0.4× 193 1.2× 74 1.0× 52 0.8× 26 396
Laura N. Mutton United States 9 236 0.8× 82 0.4× 204 1.3× 90 1.2× 28 0.4× 10 380
Jindong Sheng China 13 150 0.5× 78 0.4× 107 0.7× 80 1.1× 46 0.7× 17 400
Huichuan Jiang China 10 193 0.7× 112 0.6× 93 0.6× 86 1.2× 73 1.1× 14 347
Chengyun Yao China 13 271 0.9× 132 0.7× 122 0.8× 138 1.9× 43 0.6× 27 482

Countries citing papers authored by Ju Guo

Since Specialization
Citations

This map shows the geographic impact of Ju Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Guo more than expected).

Fields of papers citing papers by Ju Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Guo. The network helps show where Ju Guo may publish in the future.

Co-authorship network of co-authors of Ju Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Guo. A scholar is included among the top collaborators of Ju Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Guo. Ju Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Sheng, Zhongqi Li, Lin Yang, et al.. (2024). USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer. Cell Death and Disease. 15(11). 790–790. 4 indexed citations
2.
Li, Sheng, Zhongqi Li, Yanping Song, et al.. (2024). A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling. Oncogene. 43(36). 2696–2707. 2 indexed citations
3.
Gao, Yi, et al.. (2024). Recent advances in peptoids as promising antimicrobial agents to target diverse microbial species. European Journal of Medicinal Chemistry. 280. 116982–116982. 4 indexed citations
4.
5.
Chen, Haiyan, et al.. (2023). RNA-binding MSI proteins and their related cancers: A medicinal chemistry perspective. Bioorganic Chemistry. 143. 107044–107044.
6.
Zhou, Qiang, et al.. (2023). CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia. Cell Death and Disease. 14(10). 658–658. 5 indexed citations
7.
Ding, Yi, et al.. (2022). HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways. Journal of Cancer Research and Clinical Oncology. 149(1). 79–90. 9 indexed citations
8.
Deng, Wen, Ke Zhu, Ru Chen, et al.. (2022). Novel circular RNA circ_0086722 drives tumor progression by regulating the miR-339-5p/STAT5A axis in prostate cancer. Cancer Letters. 533. 215606–215606. 23 indexed citations
9.
Pan, Qiufeng, et al.. (2022). ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma. Journal of Cancer. 13(8). 2504–2514. 12 indexed citations
10.
Deng, Wen, Cheng Zhang, Hao Jiang, et al.. (2021). Transvesical Versus Posterior Approach to Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Retrospective Comparison With a 12-Month Follow-Up. Frontiers in Oncology. 11. 641887–641887. 13 indexed citations
11.
Zhou, Xiaochen, Bin Fu, Cheng Zhang, et al.. (2020). Transvesical robot‐assisted radical prostatectomy: initial experience and surgical outcomes. British Journal of Urology. 126(2). 300–308. 23 indexed citations
12.
Hu, Jieping, et al.. (2020). LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation. Molecular and Cellular Probes. 53. 101607–101607. 10 indexed citations
13.
Guo, Ju, Xiaochen Zhou, Cheng Zhang, Gongxian Wang, & Bin Fu. (2019). Comparison Studies of “Ultrathin Parenchyma” Resection and Sharp Dissection in Robotic Partial Nephrectomy for Renal Tumors. Journal of Endourology. 34(3). 281–288. 2 indexed citations
15.
Fu, Bin, Yibing Wang, Xiali Zhang, et al.. (2015). miR-221-induced PUMA silencing mediates immune evasion of bladder cancer cells. International Journal of Oncology. 46(3). 1169–1180. 18 indexed citations
16.
Guo, Ju. (2012). Clinical presentation,histology and prognosis of mucosal melanoma in ethnic Chinese:A study of 212 consecutive cases. Chinese Clinical Oncology. 1 indexed citations
17.
Guo, Ju. (2012). Interpretation of clinical practice guidelines for management of melanoma in China(new version of 2011). Chinese Clinical Oncology. 1 indexed citations
18.
Guo, Ju. (2010). C-KIT gene amplification in 262 Chinese melanoma patients. Chinese Clinical Oncology. 1 indexed citations
19.
Guo, Ju. (2009). BRAF mutation in Chinese melanoma patients. Chinese Clinical Oncology. 2 indexed citations
20.
Guo, Ju. (2005). The prevalence of osteonecrosis in severe acute respiratory syndrome patients: an MRI screening study. Zhonghua fangshexian yixue zazhi. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026